$AIP

JANAC K CHARLES sold $2.4M of AIP (indirect holdings)

JANAC K CHARLES (President and CEO) sold 70,000 indirectly-held shares of Arteris, Inc. (AIP) at an average of $34.91 ($34.74–$35.16, $2.44M total) across 2 trades on 2026-06-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JANAC K CHARLES
Published Jun 10, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 10, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest disclosed fact is the CEO/10% owner’s open-market sale of 70,000 shares at ~$34.74–$35.16 on June 8, filed June 10, under a pre-arranged 10b5-1 plan.

02

Market read

Primarily a sentiment/positioning datapoint; limited fundamental impact expected due to 10b5-1 context.

03

What to watch

The article doesn’t state whether the sale was part of a broader planned schedule, nor does it include any concurrent buys by insiders or changes in guidance/operations.

Relevance 5/10Novelty 6/10Timing: Filed June 10; sale executed June 8.

Background

The article is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP).

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris CEO/10% owner JANAC K CHARLES sold ~$2.44M of AIP shares via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived unless paired with other catalysts.

Evidence & confidence

The filing is a primary-source insider sale with a stated 10b5-1 plan, which typically reduces the informational content versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider liquidity/positioning.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with management de-risking ahead of other events; traders may watch for follow-on filings.

Key entities

  • Arteris, Inc.

    Company whose shares were sold by its CEO/10% owner under a 10b5-1 plan.

  • JANAC K CHARLES

    President and CEO; officer/director/10% owner who executed the sale.

Related articles

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn